secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mineralys Therapeutics, Inc. (MLYS)
CIK:        0001933414
Form:       8-K
Filed at:   2023-02-14T23:59:59+00:00
Accession:  0001628280-23-003502
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mineralys Therapeutics closes IPO of 13.8M shares at $16, raising $220.8M
-------------------------------------------------------------------------

- Completed IPO of 13,800,000 shares (including full exercise of underwriters' option) at $16.00 per share.
- Gross proceeds of $220.8 million before underwriting discounts and offering expenses.
- Filed amended charter increasing authorized common stock to 500M shares and authorizing 50M shares of preferred stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933414/000162828023003502/0001628280-23-003502-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933414/000162828023003502/mineralys-8xk.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-003502

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer